In 2022, China was the leading country of origin for medical drug substances imported into South Korea, with an import value of around 916.9 million U.S. dollars. This was followed by India and Japan. That year, China was also one of the leading countries of origin for all
Leading countries of origin of medical drug substances imported into South Korea in 2022, by import value (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Import value of pharmaceuticals into Finland 2013-2022
- Premium Statistic Pharmaceutical product imports in Chile 2014-2022
- Premium Statistic Pharmaceutical imports in Colombia 2013-2022
- Basic Statistic Italy: leading suppliers of imported pharmaceutical products 2017-2019
- Premium Statistic Import value of pharmaceutical products in Poland 2011-2022
- Premium Statistic Pharmaceutical imports in Costa Rica 2013-2022
- Premium Statistic Pharmaceutical imports in the Dominican Republic 2013-2022
- Premium Statistic Pharmaceutical imports in Ecuador 2013-2022
- Premium Statistic Pharmaceutical imports in Peru 2013-2022
- Premium Statistic Pharmaceutical imports in Argentina 2013-2022
About the region
10
- Basic Statistic Revenue of pharmaceutical company Recordati 2022, by product
- Premium Statistic Members of EFPIA's pharmaceutical market value 2000-2022
- Basic Statistic Olon worldwide revenue 2016-2021
- Basic Statistic Olon company profit 2016-2021
- Basic Statistic Dipharma Francis revenue 2016-2022
- Basic Statistic Dipharma Francis: profit 2016-2022
- Basic Statistic Orphan drug sales worldwide by therapy category 2028
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2023-2028
- Basic Statistic Average number of outstanding shares of Sanofi 2009-2023
- Basic Statistic Basic earnings per share of Sanofi 2009-2023
Selected statistics
7
- Premium Statistic Annual revenue of Sinopharm 2010-2022
- Premium Statistic Number of employees at Sinopharm 2011-2022
- Premium Statistic Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Premium Statistic Revenue of Sinopharm 2011-2022, by category
- Basic Statistic M&A capacities - changes for the global pharma industry 2008-2015
- Premium Statistic Pfizer's ad spending 2006-2023
- Premium Statistic Enterprise and brand value of Shoppers Drug Mart in 2012
Other regions
10
- Basic Statistic Import value of pharmaceuticals into Sweden 2012-2022
- Premium Statistic Brazil: imports value of consumer-oriented products from Mercosur 2011-2017
- Premium Statistic Value of pharmaceutical product imports in Australia 2008-2019
- Premium Statistic Import value of goods in Russia from APAC 2010-2019
- Premium Statistic Import partners of Denmark for enzymes 2016, by import value
- Basic Statistic Cumulative price change of orphan drugs in the U.S. 2012-2014
- Premium Statistic Sideral market share out of total food supplements market value in Italy 2008-2022
- Premium Statistic Pharmaceutical imports in Bolivia 2014-2022
- Premium Statistic Pharmaceutical imports in Uruguay 2013-2022
- Premium Statistic Monthly value of gland imports into Finland 2018
Related statistics
10
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic Net income Yuhan 2015-2022
Further related statistics
9
- Sanofi's total assets 2007-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Johnson & Johnson's number of employees 2004-2023
Further Content: You might find this interesting as well
Statistics
- Sanofi's total assets 2007-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Johnson & Johnson's number of employees 2004-2023
MFDS (South Korea). (December 28, 2023). Leading countries of origin of medical drug substances imported into South Korea in 2022, by import value (in million U.S. dollars) [Graph]. In Statista. Retrieved April 26, 2024, from https://www.statista.com/statistics/1296868/south-korea-leading-origin-countries-for-raw-material-imports-by-value/
MFDS (South Korea). "Leading countries of origin of medical drug substances imported into South Korea in 2022, by import value (in million U.S. dollars)." Chart. December 28, 2023. Statista. Accessed April 26, 2024. https://www.statista.com/statistics/1296868/south-korea-leading-origin-countries-for-raw-material-imports-by-value/
MFDS (South Korea). (2023). Leading countries of origin of medical drug substances imported into South Korea in 2022, by import value (in million U.S. dollars). Statista. Statista Inc.. Accessed: April 26, 2024. https://www.statista.com/statistics/1296868/south-korea-leading-origin-countries-for-raw-material-imports-by-value/
MFDS (South Korea). "Leading Countries of Origin of Medical Drug Substances Imported into South Korea in 2022, by Import Value (in Million U.S. Dollars)." Statista, Statista Inc., 28 Dec 2023, https://www.statista.com/statistics/1296868/south-korea-leading-origin-countries-for-raw-material-imports-by-value/
MFDS (South Korea), Leading countries of origin of medical drug substances imported into South Korea in 2022, by import value (in million U.S. dollars) Statista, https://www.statista.com/statistics/1296868/south-korea-leading-origin-countries-for-raw-material-imports-by-value/ (last visited April 26, 2024)
Leading countries of origin of medical drug substances imported into South Korea in 2022, by import value (in million U.S. dollars) [Graph], MFDS (South Korea), December 28, 2023. [Online]. Available: https://www.statista.com/statistics/1296868/south-korea-leading-origin-countries-for-raw-material-imports-by-value/